Titre : Toxines bactériennes

Toxines bactériennes : Questions médicales fréquentes

Termes MeSH sélectionnés :

Immunization Programs
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Toxines bactériennes : Questions médicales les plus fréquentes", "headline": "Toxines bactériennes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Toxines bactériennes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-30", "dateModified": "2025-03-25", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Toxines bactériennes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Toxines biologiques", "url": "https://questionsmedicales.fr/mesh/D014118", "about": { "@type": "MedicalCondition", "name": "Toxines biologiques", "code": { "@type": "MedicalCode", "code": "D014118", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Toxines de Bacillus thuringiensis", "alternateName": "Bacillus thuringiensis Toxins", "url": "https://questionsmedicales.fr/mesh/D000083722", "about": { "@type": "MedicalCondition", "name": "Toxines de Bacillus thuringiensis", "code": { "@type": "MedicalCode", "code": "D000083722", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.090" } } }, { "@type": "MedicalWebPage", "name": "Toxines botuliniques", "alternateName": "Botulinum Toxins", "url": "https://questionsmedicales.fr/mesh/D001905", "about": { "@type": "MedicalCondition", "name": "Toxines botuliniques", "code": { "@type": "MedicalCode", "code": "D001905", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.179" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Toxines botuliniques de type A", "alternateName": "Botulinum Toxins, Type A", "url": "https://questionsmedicales.fr/mesh/D019274", "about": { "@type": "MedicalCondition", "name": "Toxines botuliniques de type A", "code": { "@type": "MedicalCode", "code": "D019274", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.179.050" } } } ] }, { "@type": "MedicalWebPage", "name": "Facteurs cord", "alternateName": "Cord Factors", "url": "https://questionsmedicales.fr/mesh/D003311", "about": { "@type": "MedicalCondition", "name": "Facteurs cord", "code": { "@type": "MedicalCode", "code": "D003311", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.208" } } }, { "@type": "MedicalWebPage", "name": "Toxines de cyanobactéries", "alternateName": "Cyanobacteria Toxins", "url": "https://questionsmedicales.fr/mesh/D000087522", "about": { "@type": "MedicalCondition", "name": "Toxines de cyanobactéries", "code": { "@type": "MedicalCode", "code": "D000087522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.257" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Microcystines", "alternateName": "Microcystins", "url": "https://questionsmedicales.fr/mesh/D052998", "about": { "@type": "MedicalCondition", "name": "Microcystines", "code": { "@type": "MedicalCode", "code": "D052998", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.257.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Toxine diphtérique", "alternateName": "Diphtheria Toxin", "url": "https://questionsmedicales.fr/mesh/D004167", "about": { "@type": "MedicalCondition", "name": "Toxine diphtérique", "code": { "@type": "MedicalCode", "code": "D004167", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.305" } } }, { "@type": "MedicalWebPage", "name": "Endotoxines", "alternateName": "Endotoxins", "url": "https://questionsmedicales.fr/mesh/D004731", "about": { "@type": "MedicalCondition", "name": "Endotoxines", "code": { "@type": "MedicalCode", "code": "D004731", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lipopolysaccharides", "alternateName": "Lipopolysaccharides", "url": "https://questionsmedicales.fr/mesh/D008070", "about": { "@type": "MedicalCondition", "name": "Lipopolysaccharides", "code": { "@type": "MedicalCode", "code": "D008070", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lipide A", "alternateName": "Lipid A", "url": "https://questionsmedicales.fr/mesh/D008050", "about": { "@type": "MedicalCondition", "name": "Lipide A", "code": { "@type": "MedicalCode", "code": "D008050", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.500" } } }, { "@type": "MedicalWebPage", "name": "Antigènes O", "alternateName": "O Antigens", "url": "https://questionsmedicales.fr/mesh/D019081", "about": { "@type": "MedicalCondition", "name": "Antigènes O", "code": { "@type": "MedicalCode", "code": "D019081", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Lipide A", "alternateName": "Lipid A", "url": "https://questionsmedicales.fr/mesh/D008050", "about": { "@type": "MedicalCondition", "name": "Lipide A", "code": { "@type": "MedicalCode", "code": "D008050", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.500" } } }, { "@type": "MedicalWebPage", "name": "Antigènes O", "alternateName": "O Antigens", "url": "https://questionsmedicales.fr/mesh/D019081", "about": { "@type": "MedicalCondition", "name": "Antigènes O", "code": { "@type": "MedicalCode", "code": "D019081", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.329.500.600" } } } ] }, { "@type": "MedicalWebPage", "name": "Toxine tétanique", "alternateName": "Tetanus Toxin", "url": "https://questionsmedicales.fr/mesh/D013744", "about": { "@type": "MedicalCondition", "name": "Toxine tétanique", "code": { "@type": "MedicalCode", "code": "D013744", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D23.946.123.893" } } } ], "about": { "@type": "MedicalCondition", "name": "Toxines bactériennes", "alternateName": "Bacterial Toxins", "code": { "@type": "MedicalCode", "code": "D001427", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Angela C Brown", "url": "https://questionsmedicales.fr/author/Angela%20C%20Brown", "affiliation": { "@type": "Organization", "name": "Department of Chemical and Biomolecular Engineering, Lehigh University, Bethlehem, PA 18015, USA. Electronic address: acb313@lehigh.edu." } }, { "@type": "Person", "name": "Michel R Popoff", "url": "https://questionsmedicales.fr/author/Michel%20R%20Popoff", "affiliation": { "@type": "Organization", "name": "Bacteries Anaerobies et Toxines, Institut Pasteur, 28 rue du Docteur Roux, 75724 Paris, France." } }, { "@type": "Person", "name": "Noam Dotan", "url": "https://questionsmedicales.fr/author/Noam%20Dotan", "affiliation": { "@type": "Organization", "name": "Department of Brain Sciences, Weizmann Institute of Science, Rehovot, Israel." } }, { "@type": "Person", "name": "Asaf Levy", "url": "https://questionsmedicales.fr/author/Asaf%20Levy", "affiliation": { "@type": "Organization", "name": "Department of Plant Pathology and Microbiology, Institute of Environmental Science, The Faculty of Agriculture, Food, and Environment, The Hebrew University of Jerusalem, Rehovot, Israel." } }, { "@type": "Person", "name": "Sara Travaglione", "url": "https://questionsmedicales.fr/author/Sara%20Travaglione", "affiliation": { "@type": "Organization", "name": "Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, 00161 Rome, Italy." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.", "datePublished": "2023-04-26", "url": "https://questionsmedicales.fr/article/37099400", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2023.2194190" } }, { "@type": "ScholarlyArticle", "name": "Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan.", "datePublished": "2023-03-16", "url": "https://questionsmedicales.fr/article/36933984", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.vaccine.2023.03.007" } }, { "@type": "ScholarlyArticle", "name": "A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.", "datePublished": "2022-06-15", "url": "https://questionsmedicales.fr/article/35703731", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/21645515.2022.2079305" } }, { "@type": "ScholarlyArticle", "name": "The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.", "datePublished": "2023-11-13", "url": "https://questionsmedicales.fr/article/37957695", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12960-023-00869-7" } }, { "@type": "ScholarlyArticle", "name": "Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs.", "datePublished": "2024-09-09", "url": "https://questionsmedicales.fr/article/39252041", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s41043-024-00615-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Facteurs biologiques", "item": "https://questionsmedicales.fr/mesh/D001685" }, { "@type": "ListItem", "position": 3, "name": "Toxines biologiques", "item": "https://questionsmedicales.fr/mesh/D014118" }, { "@type": "ListItem", "position": 4, "name": "Toxines bactériennes", "item": "https://questionsmedicales.fr/mesh/D001427" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Toxines bactériennes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Toxines bactériennes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Toxines bactériennes", "description": "Comment diagnostiquer une intoxication par toxines bactériennes ?\nQuels tests sont utilisés pour détecter les toxines ?\nLes symptômes peuvent-ils indiquer le type de toxine ?\nLes analyses sanguines sont-elles utiles ?\nComment différencier les toxines bactériennes des autres ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Toxines bactériennes", "description": "Quels sont les symptômes courants d'une intoxication ?\nLes symptômes varient-ils selon la toxine ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux enfants ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Toxines bactériennes", "description": "Comment prévenir les intoxications alimentaires ?\nLes vaccins peuvent-ils prévenir certaines toxines ?\nQuelles pratiques alimentaires sont recommandées ?\nComment éviter la contamination croisée ?\nLes enfants doivent-ils être surveillés lors des repas ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Toxines bactériennes", "description": "Quel est le traitement principal pour une intoxication ?\nLes antibiotiques sont-ils efficaces contre les toxines ?\nQuand faut-il hospitaliser un patient ?\nY a-t-il des antidotes pour les toxines ?\nComment gérer les symptômes sévères ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Toxines bactériennes", "description": "Quelles complications peuvent survenir après une intoxication ?\nLes complications sont-elles fréquentes ?\nComment les complications sont-elles traitées ?\nLes complications peuvent-elles être évitées ?\nLes complications affectent-elles les personnes âgées différemment ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Toxines bactériennes", "description": "Quels sont les principaux facteurs de risque d'intoxication ?\nLes personnes immunodéprimées sont-elles plus à risque ?\nLes voyages augmentent-ils le risque d'intoxication ?\nLes enfants sont-ils plus à risque d'intoxication ?\nLes personnes âgées sont-elles plus vulnérables ?", "url": "https://questionsmedicales.fr/mesh/D001427?mesh_terms=Immunization+Programs&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication par toxines bactériennes ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique clinique, les symptômes et des tests de laboratoire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les toxines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests immunologiques et des cultures bactériennes sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer le type de toxine ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes spécifiques peuvent aider à identifier la toxine responsable." } }, { "@type": "Question", "name": "Les analyses sanguines sont-elles utiles ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent révéler des signes d'infection ou d'inflammation, mais ne détectent pas toujours les toxines." } }, { "@type": "Question", "name": "Comment différencier les toxines bactériennes des autres ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'analyse des symptômes et des antécédents d'exposition aide à la différenciation." } }, { "@type": "Question", "name": "Quels sont les symptômes courants d'une intoxication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent nausées, vomissements, diarrhée et douleurs abdominales." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la toxine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque toxine peut provoquer un ensemble de symptômes distincts." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Certaines toxines, comme celles de Clostridium, peuvent provoquer des symptômes neurologiques." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent apparaître rapidement, souvent dans les heures suivant l'exposition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux enfants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les enfants peuvent présenter des symptômes plus graves, comme la déshydratation." } }, { "@type": "Question", "name": "Comment prévenir les intoxications alimentaires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La cuisson adéquate des aliments et l'hygiène sont essentielles pour prévenir les intoxications." } }, { "@type": "Question", "name": "Les vaccins peuvent-ils prévenir certaines toxines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccins existent pour prévenir des maladies causées par certaines toxines, comme le tétanos." } }, { "@type": "Question", "name": "Quelles pratiques alimentaires sont recommandées ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les aliments crus ou mal cuits et respecter les dates de péremption." } }, { "@type": "Question", "name": "Comment éviter la contamination croisée ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des planches à découper séparées pour les viandes et les légumes aide à prévenir la contamination." } }, { "@type": "Question", "name": "Les enfants doivent-ils être surveillés lors des repas ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la surveillance des enfants pendant les repas peut prévenir les risques d'intoxication." } }, { "@type": "Question", "name": "Quel est le traitement principal pour une intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la réhydratation et le soutien symptomatique." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre les toxines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ne neutralisent pas les toxines, mais traitent l'infection bactérienne." } }, { "@type": "Question", "name": "Quand faut-il hospitaliser un patient ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "L'hospitalisation est nécessaire en cas de symptômes graves ou de déshydratation sévère." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour les toxines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Certains cas, comme le botulisme, disposent d'antidotes spécifiques." } }, { "@type": "Question", "name": "Comment gérer les symptômes sévères ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les soins intensifs peuvent être nécessaires pour gérer les symptômes sévères." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir après une intoxication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications comme la déshydratation, le choc ou des lésions organiques peuvent survenir." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont rares mais peuvent être graves, surtout chez les personnes vulnérables." } }, { "@type": "Question", "name": "Comment les complications sont-elles traitées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement des complications nécessite souvent des soins médicaux intensifs." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une détection précoce et un traitement rapide peuvent réduire le risque de complications." } }, { "@type": "Question", "name": "Les complications affectent-elles les personnes âgées différemment ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées sont plus susceptibles de développer des complications graves." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque d'intoxication ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent une mauvaise hygiène, la consommation d'aliments crus et des conditions de stockage inadéquates." } }, { "@type": "Question", "name": "Les personnes immunodéprimées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles sont plus vulnérables aux infections et aux effets des toxines." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'intoxication ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les voyages dans des régions avec de mauvaises pratiques alimentaires augmentent le risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque d'intoxication ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en raison de leur système immunitaire moins développé et de comportements alimentaires." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus vulnérables ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent avoir un système immunitaire affaibli et des comorbidités." } } ] } ] }

Sources (10000 au total)

Differential coverage for vaccines in the expanded program on immunization (EPI) among children in rural Pakistan.

Pakistan has a well-established Expanded Program on Immunization (EPI) however vaccine-preventable diseases still account for high infant and child mortality rates. This study describes the differenti... From October 2014 to September 2018, we enrolled children younger than 2 years of age from the Matiari Demographic Surveillance System in Sindh, Pakistan. Socio-demographic and vaccination history wer... Of the 3140 enrolled children, 48.4 % received all EPI recommended vaccines. Only 21.2 % of these were age appropriate. Around 45.4 % of the children were partially vaccinated, and 6.2 % were unvaccin... Vaccine coverage was low among children in Matiari, Pakistan, and majority received delayed doses. Parents' education status and year of study enrollment was protective against vaccine dropout and del...

A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia.

In response to the substantial clinical and economic burden of diseases caused by... A Markov model that simulated the disease processes of invasive pneumococcal disease (IPD), pneumonia, and acute otitis media (AOM) over a newborn cohort lifetime was used to evaluate the cost-effecti... Vaccination with PHiD-CV or PCV13 was estimated to avert approximately 700 cases of IPD (200 meningitis, 500 bacteremia), and around 5,000 cases of all-cause pneumonia. However, PHiD-CV vaccination wa... PCVs are a cost-effective strategy to relieve the burden associated with diseases caused by...

The faces behind vaccination: unpacking the attitudes, knowledge, and practices of staff of Cameroon's Expanded program on Immunization.

Immunization is regarded as one of the most cost-effective public health interventions in global health. However, its cost-effectiveness depends greatly on the knowledge and skills of vaccinators. Wit... Through a descriptive cross-sectional design, we used structured questionnaires and observation guides to collect data from vaccination staff in health facilities that were selected by a multistage sa... Overall, we collected data from Expanded Program on Immunization focal staff in 265 health facilities across 68 health districts. Over half (53%) of the surveyed facilities were found in rural areas. ... This study suggests marked deficits in immunization knowledge among vaccination staff and exposes common attitudes and practices that could contribute to missed opportunities for vaccination and hinde...

Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs.

In this article we analyzed the extent of the usage of Theories of Change (TOCs) and causal pathways in the evaluation of immunization programs to identify the challenges to generating evidence on how... We analyzed the use of the TOC in impact evaluations (IEs) of immunization interventions published after 2010, and its associated articles. The review includes studies from Evidence Gap Map and Yale r... Our review included 47 large-scale and 45 small-to medium-scale interventions. Of the included studies, 19% used a TOC, 56% described a causal pathway or used a conceptual diagram with varying degrees... Future implementers and evaluators need to develop clear TOCs that are based on established theory and have clearly articulated the underlying assumptions. Large-scale health system strengthening init...

Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018).

Rotavirus (RV) vaccination was included in the Finnish National immunization Program (NIP) in 2009. RotaTeq (RV5) has been used exclusively with a national average vaccination coverage rate (VCR) of >... We first describe the incidence of RVGE, viral gastroenteritis (VGE), and acute gastroenteritis (AGE) for all Finnish children born during 2008-2011. Children were stratified by the year of birth into... RVGE incidence decreased significantly soon after implementation of RV vaccination in the NIP. In vaccine-eligible cohorts, no clear peak incidence in the youngest age groups could be observed, and no... Incidence of RVGE has remained low in all age groups during the 10 years following introduction of RV vaccine in the Finnish NIP. Differences in RVGE incidence were observed in regions with high as co...

Comprehensive assessment of the implementation of maternal immunization programs in Italy: A national survey across maternity care units.

The authors aimed to assess the characteristics and integration of immunization services into the prenatal care provided by maternity care units (MCUs) in Italy.... A cross-sectional nationwide study using a web-based survey was conducted from June to August 2021. The study population consisted of 342 obstetricians/gynecologists (OB/GYNs), members of the Italian ... Overall, 112 of 342 MCUs completed the survey, for an overall response rate of 32.7%. Almost all MCUs (96.4%) provided vaccine information, but only 22% had an onsite vaccination clinic. Less than hal... Institutional barriers and lack of certain vaccine-related services offered during prenatal care in Italian MCUs might be responsible for many missed vaccination opportunities. Embedding maternal immu...

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe.

Delaying of policies for immunization of aging adults, low vaccine uptake, and the lack of supportive evidence at the national level could diminish the value in health and economics of such programs. ... The tool was developed in two phases. First, a modified Delphi process was used to construct the tool. The process included a literature review, stakeholder consultations, and a three-round Delphi stu... The review identified 16 tools and frameworks that formed the first version of our tool with 14 items. Eight experts were involved in the Delphi panel. Through three Delphi rounds, four items were add... Through a thorough and transparent process, a country score tool was developed helping to identify strengths, weaknesses, and evidential requirements for decision-making and implementation of immuniza...